These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37298922)

  • 21. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.
    Dehnes Y; Hemmersbach P
    Drug Test Anal; 2011 May; 3(5):291-9. PubMed ID: 21387570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Horseradish-peroxidase-conjugated anti-erythropoietin antibodies for direct recombinant human erythropoietin detection: Proof of concept.
    Voss SC; Orie NN; El-Saftawy W; Saghbazarian S; Al-Kaabi A; Georgakopoulos C; Athanasiadou I; Mohamed-Ali V; Al-Maadheed M
    Drug Test Anal; 2021 Mar; 13(3):529-538. PubMed ID: 33119945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.
    Desharnais P; Naud JF; Ayotte C
    Drug Test Anal; 2013; 5(11-12):870-6. PubMed ID: 23720238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An optimized SDS-PAGE protocol with a new blotting system for the initial testing procedure of ESAs in doping control.
    Martin L; Martin JA; Audran M; Marchand A
    Drug Test Anal; 2022 Jan; 14(1):181-187. PubMed ID: 33269539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.
    Okano M; Sato M; Kaneko E; Kageyama S
    Drug Test Anal; 2011; 3(11-12):798-805. PubMed ID: 22012825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARCOSYL-PAGE: Optimized Protocols for the Separation and Immunological Detection of PEGylated Proteins.
    Reichel C; Gmeiner G; Reihlen P; Thevis M; Schänzer W
    Methods Mol Biol; 2019; 1855():131-149. PubMed ID: 30426415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research on spiking rat EPO as internal standard in doping control samples for detection of EPO using SAR-PAGE analysis with biotinylated primary antibody.
    Zhou X; He S; Zhang L; Shen L; He C
    Drug Test Anal; 2020 Aug; 12(8):1054-1064. PubMed ID: 32449841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of erythropoiesis stimulating agents in urine samples using a capillary Western system.
    Desharnais P; Naud JF; Ayotte C
    Drug Test Anal; 2018 Nov; 10(11-12):1698-1707. PubMed ID: 30365250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent developments in doping testing for erythropoietin.
    Reichel C
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin (EPO) immunoaffinity columns--a powerful tool for purifying EPO and its recombinant analogues.
    Dehnes Y; Lamon S; Lönnberg M
    J Pharm Biomed Anal; 2010 Dec; 53(4):1028-32. PubMed ID: 20656433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defending Dynepo detection.
    Gmeiner G; Reichel C; Kulovics R; Scheiblhofer V
    Drug Test Anal; 2010; 2(11-12):526-32. PubMed ID: 21204285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination methods for erythropoietin receptor activator in human urine].
    Xing YY; Zhang LS; Xu YX; Wu MT; Wang S
    Yao Xue Xue Bao; 2009 Jul; 44(7):820-3. PubMed ID: 19806926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dried blood spots for erythropoietin analysis: Detection of micro-doses, EPO c.577del variant and comparison with in-competition matching urine samples.
    Heiland CE; Martin L; Zhou X; Zhang L; Ericsson M; Marchand A
    Drug Test Anal; 2024 Jun; 16(6):650-654. PubMed ID: 37942506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels.
    Kohler M; Ayotte C; Desharnais P; Flenker U; Lüdke S; Thevis M; Völker-Schänzer E; Schänzer W
    Int J Sports Med; 2008 Jan; 29(1):1-6. PubMed ID: 18050057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of a nonerythropoietic erythropoietin, Neuro-EPO, in blood after intranasal administration in rat.
    Martin L; Garcia Rodriguez JC; Audran M; Ericsson M; Maurice T; Marchand A
    Drug Test Anal; 2020 Nov; 12(11-12):1605-1613. PubMed ID: 32856413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin and erythropoiesis stimulating agents.
    Debeljak N; Sytkowski AJ
    Drug Test Anal; 2012 Nov; 4(11):805-12. PubMed ID: 22508651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry.
    Stübiger G; Marchetti M; Nagano M; Reichel C; Gmeiner G; Allmaier G
    Rapid Commun Mass Spectrom; 2005; 19(5):728-42. PubMed ID: 15700237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of EPO-Fc fusion protein in human blood: screening and confirmation protocols for sports drug testing.
    Reichel C; Thevis M
    Drug Test Anal; 2012 Nov; 4(11):818-29. PubMed ID: 22764129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of high intensity exercise on isoelectric profiles and SDS-PAGE mobility of erythropoietin.
    Voss S; Lüdke A; Romberg S; Schänzer E; Flenker U; deMarees M; Achtzehn S; Mester J; Schänzer W
    Int J Sports Med; 2010 Jun; 31(6):367-71. PubMed ID: 20419620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design.
    Reichel C
    Drug Test Anal; 2011; 3(11-12):883-91. PubMed ID: 22140023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.